Faculty Profile for Dr. Arzu Ari

profile photo for Dr. Arzu Ari
Dr. Arzu Ari
Professor — Department of Respiratory Care
WILW 233
phone: (512) 716-2691

Biography Section

Biography and Education

Dr. Arzu Ari is a physical therapist and a respiratory therapist by training with 25 years of experience as a manager, clinician, educator and researcher. She is the first Turkish physical therapist who passed the National Board for Respiratory Care Exams for respiratory therapists and pulmonary function technologists. After she graduated from the Department of Physical Therapy and Rehabilitation at Hacettepe University in Ankara, Turkish Republic, Dr. Ari completed her master’s degree in public health at Istanbul University. She received her second master’s degree in respiratory therapy and PhD degree in higher education administration from Georgia State University. Currently, Dr. Ari teaches in the Department of Respiratory Care at Texas State University.

Teaching Interests

Dr. Ari has been teaching undergraduate and graduate level courses since January 2000. She has maintained quality teaching and earned exemplary evaluations. Her overall teaching effectiveness and overall rating for courses average 4.8 and 4.5.

Since her employment in the Department of Respiratory Therapy at Texas State University in September 2017, Dr. Ari has developed three courses: (1) RC 5305, a new graduate level applied research course. (2) RC 5307, an online graduate level advanced seminar course, and (3) RC 3212, an undergraduate level online respiratory pharmacology course. In each course that she developed, Dr Ari implemented one-on-one meetings, online supplements, lectures, in-class activities, student presentations, homework, projects and discussion forums, exploding the advantages of each for the benefit of student learning.

Research Interests

Dr. Ari’s primary area of research is aerosol medicine which is closely tied to four major developments that have had a global impact on the practice of aerosol drug delivery to patients with pulmonary diseases by (1) Helping clinicians understand current practices of aerosol drug therapy, (2) Identifying the best practices of aerosol drug delivery not only in spontaneously breathing patients but also in critical care environment. (3) Evaluating the performance of aerosol delivery devices to optimize inhaled drug delivery in patients with respiratory disorders and (4) Generating new concepts and methods that optimize aerosol drug administration to adults, pediatrics, infants and newborns. Dr. Ari evaluates in-vitro characterization of medical aerosols from various types of aerosol delivery systems used in the treatment of pulmonary diseases to help improve drug delivery in adult, pediatrics and infants. Her research laboratory is one of only a few in the world that can bring together the pharmaceutical, aerosol and respiratory care talent and infrastructure needed to support innovative research, build consensus and make strides in the field.

Dr. Ari’s current position affords her the facilities and the finances to continue her groundbreaking research in the field of respiratory care, which has a direct impact on the health of patients with lung diseases like asthma, cystic fibrosis, and chronic obstructive pulmonary disease in both the United States and abroad. Furthermore, her work is the foundation from which others are performing research with direct clinical applications. For example, her work has led to amazing contributions in novel methods of aerosol delivery to neonates, infants, children and adults. With such outstanding accomplishments to date, Dr. Ari has been recognized as an outstanding researcher/professor in the field of aerosol research and her work received the prestigious Monaghan/Trudell Fellowship for Aerosol Technique Development from the American Respiratory Care Foundation three times in the past 10 years.

Dr. Ari’s interest in research has manifested in 72 abstracts, 57 peer-reviewed articles, 12 book chapters 2 clinical practice guidelines and 2 books. She is the first author of the book entitled “A Guide to Aerosol Delivery Devices for Respiratory Therapists, 2nd ed.” that was downloaded by approximately 3 million people around the world and translated into Spanish, Chinese, Italian, Turkish and Arabic. I also co-authored several book chapters published in Egan’s Fundamentals of Respiratory Care, Rau’s Respiratory Pharmacology, Neonatal and Pediatric Respiratory Care, Aerosol Drug Delivery and Cairo’s Respiratory Therapy Equipment. She has spoken at a variety of national and international professional congresses.

Selected Scholarly/Creative Work

  • Hanania, N., Braman, S., Adams, S. G., Adewuya, R., Ari, A., … Peters, J. (2018). The role of inhalation delivery devices in COPD: Perspectives of patients and health care providers. Chronic Obstructive Pulmonary Disease (COPD), 5(2), 1–13.
  • Ari, A., braman, S. S., Mahler, D. A., & Ohar, J. A. (2018). The importance of device considerations in COPD treatment selection. CHEST Physicians, 1–8.
  • Ari, A., & Mahler, D. A. (2018). Individualizing COPD medication delivery devices: Guidelines, Challenges, and Solutions. How to partner with your patients to help optimize treatment-device selection. CHEST Physicians, 9–14.
  • Ari, A. (2017). Aerosol drug delivery through high flow nasal cannula. Current Pharmaceutical Biotechnology, 18(11).
  • Ari, A., Dang, T., Alqahtani, M., Alanazi, F., Alkhathami, A., Qoutah, R., … Fink, J. (2017). Effect of HME on aerosol drug delivery and airway resistance in simulated ventilator dependent adults using jet and mesh nebulizers. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 3(1), 42–48.

Selected Awards

  • Award / Honor Recipient: 2018 Mitchell A. Baran Achievement Award for Clinical Excellence in Aerosol and Airway Clearance Therapies. December 4, 2018
  • Award / Honor Recipient: Fellow of the American Association for Respiratory Care (FAARC)., American Association for Respiratory Care (AARC). November 5, 2011
  • Award / Honor Recipient: Best Poster Presentation Award, Turkish Respiratory Society. October 20, 2011
  • Award / Honor Recipient: Volunteer Excellence Award., American Association for Respiratory Care (AARC). December 4, 2009
  • Award / Honor Recipient: Governor for Turkey, International Council for Respiratory Care. 1997 - Present

Selected Grants

  • Ari, Arzu. Impact of Filtered HME on Aerosol Deposition and Particle Size Measurement in Simulated Mechanically Ventilated Adult Lung Model, ARC Medical, Private / Foundation / Corporate, $6436.55. (Funded: April 2018 - December 2019). Grant.
  • Ari, Arzu. Effect of HME on Aerosol Drug Delivery and Airway Resistance in Simulated Ventilator Dependent, ARC Medical, $17950. (Funded: April 21, 2016 - April 30, 2017). Grant.
  • Ari, Arzu. Performance Comparisons of Two Nebulizers in Simulated Spontaneously Breathing Adults and Pediatric, Aerogen Ltd, $15000. (Funded: April 18, 2013 - April 18, 2014). Grant.
  • Ari, Arzu. Quantifying Aerosol Delivery and Humidification in Spontaneously Breathing Patients with Tracheostomy, American Respiratory Care Foundation, $10000. (Funded: August 15, 2012 - August 14, 2013). Grant.
  • Ari, Arzu. Comparisons of jet and mesh nebulizers using mouthpiece, face mask and high flow nasal cannula in simulated spontaneously breathing children, Texas State University. (Funded: January 2018 - June 2019). Grant.

Selected Service Activities

Editorial Review Board Member
Canadian Journal for Respiratory Care
April 2018-Present
Editorial Board Member
Journal of Aerosol Medicine and Pulmonary Drug Delivery
September 2017-Present
Committee Member
American Foundation for Respiratory Care, International Committee for Respiratory Care
January 2009-Present
Governor for Turkey, International Council for Respiratory Care
November 1997-Present
Committee Member
American College of Chest Physicians (CHEST) - COPD Delivery Makes a Difference Steering Committee
August 10, 2016-December 2017